60 results
424B5
NDRA
ENDRA Life Sciences Inc
3 Apr 24
Prospectus supplement for primary offering
5:14pm
. In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against companies … . Such litigation, if instituted against us, could result in substantial costs and diversion of management’s attention and resources, which could materially
424B5
do1pzxpxeipj59n8
28 Apr 23
Prospectus supplement for primary offering
4:51pm